We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Oral agents for cancer treatment are increasingly prescribed due to their benefits. However, oral cancer medications are difficult to handle and have a considerable potential for side effects. This type of therapy requires a high level of self-management competence by the patient. A standardized patient education program provided by physicians and oncology(More)
There is growing interest in the human sodium/iodide symporter (NIS) gene both as a molecular imaging reporter gene and as a therapeutic gene. Here, we show the feasibility of radioisotope therapy of neuroendocrine tumors. As a separate application of NIS gene transfer, we image NIS-expressing tumors with pinhole SPECT in living subjects. Biodistribution(More)
ReO 4 − has similar kinetics regarding the sodium iodide symporter (NIS) to I− and TcO 4 − in NIS-expressing tissue. We investigated the therapeutic potential of 186ReO 4 − in NIS-transfected neuroendocrine tumour tissue. For experiments, the stably NIS-transfected pancreatic neuroendocrine cancer cell line Bon1C was used. NIS-mediated internalization and(More)
  • 1